Diversified Trust’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Other funds holding BMRN
FWIA
RRAM
PCM
CF
SAM
YCM
Diversified Trust's BMRN Position: Q2 2026 in Review
Diversified Trust sold out of BioMarin Pharmaceuticals (BMRN) in Q2 2026, closing a stake of 4,880 shares — an estimated $276K sold.
Diversified Trust first reported a position in BMRN in Q2 2013 and held it in 16 quarters. The position peaked at $2.75M in Q2 2015. 56 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.
- Diversified Trust reported no remaining BioMarin Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Diversified Trust sold 4,880 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $276K.
- Diversified Trust first reported a position in BioMarin Pharmaceuticals in Q2 2013 and held it in 16 quarters.
- Diversified Trust's BioMarin Pharmaceuticals position peaked at $2.75M in Q2 2015.
- 56 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.
Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.